盐酸托莫西汀

Name: 盐酸托莫西汀
Brand: 济南圣和化工有限公司

CAS 82248-59-7C17H22ClNOMW 291.8

盐酸托莫西汀（CAS 82248-59-7）属医药中间体及原料药类产品，分子式 C17H22ClNO，分子量 291.8。济南圣和化工有限公司常年现货供应该产品，常规纯度按批次COA提供(不公开发布)，可按客户需求安排分装包装，欢迎邮件或来电询价。

产品概览

CAS号	82248-59-7
分子式	C17H22ClNO
分子量	291.8
纯度	按批次COA提供(不公开发布)
包装	按订单/批次确认(不公开发布)
应用领域	医药中间体及原料药
类别	医药中间体及原料药

应用领域

医药中间体及原料药

盐酸托莫西汀主要应用于医药中间体及原料药。具体使用工况下的添加量与规格要求，欢迎与技术团队沟通确认。

包装与储存

包装规格按订单/批次确认(不公开发布)

纯度规格按批次COA提供(不公开发布)

储存条件密封、阴凉干燥处保存

运输常规化工运输

样品可协商提供

交期现货/按订单安排

供货能力：盐酸托莫西汀备有现货，包装形式为按订单/批次确认(不公开发布)。我们支持对公转账并开具增值税发票，山东省内可安排快速配送，省外按物流时效发货，具体请联系 info@591daili.com。

质量与文件

每批产品随货提供 COA（分析证书）；可按需提供 MSDS/技术数据表及第三方检测报告。纯度与包装以批次 COA 及订单确认为准。

关于供应商

作为化工原料供应服务商，济南圣和化工有限公司长期服务于化工贸易、食品添加、医药中间体、日化原料等行业的采购需求。除盐酸托莫西汀外，您还可以在站内按 CAS 号或产品分类检索更多品类，获取规格与报价。

常见问题

盐酸托莫西汀的 CAS 号是多少？

盐酸托莫西汀的 CAS 号为 82248-59-7。

该产品的纯度和包装规格是什么？

常规纯度规格为按批次COA提供(不公开发布)，包装为按订单/批次确认(不公开发布)，随货提供 COA。

盐酸托莫西汀有什么用途？

主要应用于医药中间体及原料药。

如何购买或获取报价？

请发送邮件至 info@591daili.com 或通过 WhatsApp 联系，注明产品名称、CAS 号与需求数量，一个工作日内回复报价。供应商：济南圣和化工有限公司。

PubChem 公开数据

Description

atomoxetine hydrochloride · CAS 82248-59-7 · C17H22ClNO. UNII 57WVB6I2W0.

Identification

CAS Registry Number	82248-59-7
PubChem CID	54840
Molecular formula	C17H22ClNO
IUPAC name	(3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine;hydrochloride
UNII (FDA)	57WVB6I2W0

Computed Descriptors

Molecular Weight	291.8
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	2
Rotatable Bond Count	6
Exact Mass	291.1389920
Monoisotopic Mass	291.1389920
Topological Polar Surface Area	21.3
Heavy Atom Count	20
Formal Charge	0
Complexity	237

Physical description & handling notes

162.4 Å² [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

GHS Hazard Classification

Reported hazard statements	H301 (70%), H302 (30%), H311 (10%), H318 (70%), H319 (10%), H330 (60%), H331 (10%), H336 (30%)

H301 (70%): Toxic if swallowed [Danger Acute toxicity, oral]

H302 (30%): Harmful if swallowed [Warning Acute toxicity, oral]

Documented Uses

For the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) alone or in combination with behavioral treatment, as an adjunct to psychological, educational, social, and other remedial measures.
Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin.
Norepinephrine Uptake Inhibitors [MoA]; Norepinephrine Reuptake Inhibitor [EPC]
Atomoxetine is primarily metabolized by the CYP2D6 pathway to 4-hydroxyatomoxetine. 4-Hydroxyatomoxetine is equipotent to atomoxetine as an inhibitor of the norepinephrine transporter but circulates in plasma at much lower concentrations (1% of atomoxetine concentration in EMs and 0.1% of atomoxetine concentration in PMs). Half Life: 5 hours

Synonyms

Atomoxetine hydrochloride; 82248-59-7; Atomoxetine HCL; TOMOXETINE HYDROCHLORIDE; (R)-Tomoxetine hydrochloride; (R)-(-)-Tomoxetine hydrochloride; DTXSID2044266; LY-139603; Atomoxetine (as hydrochloride); 57WVB6I2W0; (-)-N-Methyl-3-phenyl-3-(o-tolyloxy)propylamine hydrochloride; NSC-759104; DTXCID0024266; CHEBI:331697; (-)-N-methyl-3-phenyl-3-(o-tolyloxy)-propylamine hydrochloride; HCl, Atomoxetine

Frequently Asked Questions

What are the CAS number and molecular formula of atomoxetine hydrochloride?

CAS 82248-59-7; molecular formula C17H22ClNO; molecular weight — g/mol.

What other names is atomoxetine hydrochloride known by?

Atomoxetine hydrochloride, 82248-59-7, Atomoxetine HCL, TOMOXETINE HYDROCHLORIDE, (R)-Tomoxetine hydrochloride, (R)-(-)-Tomoxetine hydrochloride.

Is atomoxetine hydrochloride classified as hazardous?

Hazard statements reported: H301, H302, H311, H318, H319.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.